Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects

European Journal of Applied Physiology

Volumn 112, Issue 8, 2012, Pages 3045-3052

  Carrillo, Andres E ^a   Flynn, Michael G ^b   Pinkston, Catherine ^c   Markofski, Melissa M ^d   Jiang, Yan ^c   Donkin, Shawn S ^c   Teegarden, Dorothy ^c  

^a PURDUE UNIVERSITY   (United States)

^b School of Business   (United States)

^c PURDUE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

25 hydroxyvitamin D; C reactive protein; Cytokine; Inflammation; Resistance training; Tumor necrosis factor

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DRUG DERIVATIVE; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MULTIMODALITY CANCER THERAPY; OBESITY; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMBINED MODALITY THERAPY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDIANA; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; OBESITY; OVERWEIGHT; RESISTANCE TRAINING; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; YOUNG ADULT;

EID: 84864886412     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-011-2279-3     Document Type: Article

References (37)

1. Armstrong L, Balady G, Berry M, Davis S, Davy B, Davy K, Franklin B, Gordon N, Lee I, McConnell T, Myers J, Pizza F, Rowland T, Stewart K, Thompson P, Wallace J (2006) ACSM's guidelines for exercise testing and prescription, 7th edn. Lippincott Williams & Wilkins, Philadelphia
2. Beavers KM, Nicklas BJ (2011) Effects of lifestyle interventions on inXammatory markers in the metabolic syndrome. Front Biosci (Schol Ed) 3:168-177
3. Bjorkman MP, Sorva AJ, Tilvis RS (2009) C-reactive protein and Wbrinogen of bedridden older patients in a six-month vitamin D supplementation trial. J Nutr Health Aging 13:435-439
4. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, Saltzman E, Dawson-Hughes B (2008) Vitamin D(3) in fat tissue. Endocrine 33:90-94
5. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G (2006) Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29:722-724 (Pubitemid 44115386)
6. Dandona P, Aljada A, Bandyopadhyay A (2004) InXammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7 (Pubitemid 38032801)
7. Donges CE, Duffield R, Drinkwater EJ (2010) Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sports Exerc 42:304-313
8. Fisher G, Hyatt TC, Hunter GR, Oster RA, Desmond RA, Gower BA (2010) EVect of diet with and without exercise training on markers of inXammation and fat distribution in overweight women. Obesity (Silver Spring) 19:1131-1136
9. Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J, McBride C (2008) Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: A comparison with non-obese controls. Obes Surg 18:145-150
10. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF (2001) Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 15:475-482 (Pubitemid 32141439)
11. Gutierrez DA, Puglisi MJ, Hasty AH (2009) Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipi-demia. Curr Diab Rep 9:26-32
12. Heaney RP (2000) Vitamin D: How much do we need, and how much is too much? Osteoporos Int 11:553-555
13. Hirschfield GM, Pepys MB (2003) C-reactive protein and cardiovascular disease: New insights from an old molecule. QJM 96:793-807 (Pubitemid 37369294)
14. Holick MF (2005) Vitamin D: Important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 98:1024-1027 (Pubitemid 41572206)
15. Jorde R, Sneve M, Torjesen P, Figenschau Y (2010a) No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 267:462-472
16. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Goransson LG, Omdal R (2010b) No effect of supplementation with cholecalciferol on cytokines and markers of inXammation in overweight and obese subjects. Cytokine 50:175-180
17. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Hansen JB, Grimnes G (2010c) No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year. Nutr J 9:1
18. Lechleitner M, Herold M, Dzien-Bischinger C, Hoppichler F, Dzien A (2002) Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years. Diabet Med 19:949-953 (Pubitemid 35356922)
19. Mauricio D, Mandrup-Poulsen T, Nerup J (1996) Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: A therapeutic perspective. Diabetes Metab Rev 12:57-68 (Pubitemid 26164839)
20. May E, Asadullah K, Zugel U (2004) Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs. Curr Drug Targets Inflamm Allergy 3:377-393 (Pubitemid 39534774)
21. McFarlin BK, Flynn MG, Campbell WW, Stewart LK, Timmerman KL (2004) TLR4 is lower in resistance-trained older women and related to inflammatory cytokines. Med Sci Sports Exerc 36:1876-1883 (Pubitemid 39473505)
22. Meshkani R, Adeli K (2009) Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 42:1331-1346
23. Myrianthefs P, Karatzas S, Venetsanou K, Grouzi E, Evagelopoulou P, Boutzouka E, Fildissis G, Spiliotopoulou I, Baltopoulos G (2003) Seasonal variation in whole blood cytokine production after LPS stimulation in normal individuals. Cytokine 24:286-292 (Pubitemid 37373664)
24. Okita K, Nishijima H, Murakami T, Nagai T, Morita N, Yonezawa K, Iizuka K, Kawaguchi H, Kitabatake A (2004) Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24:1868-1873 (Pubitemid 39350305)
25. Phillips MD, Flynn MG, McFarlin BK, Stewart LK, Timmerman KL (2010) Resistance training at eight-repetition maximum reduces the inflammatory milieu in elderly women. Med Sci Sports Exerc 42:314-325
26. Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez F, Thomas RJ, Singh P, HoVmann M, Okcay A, Korinek J, Wolk R, Somers VK (2008) Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med 5:418-425 (Pubitemid 351935576)
27. Shah A, Mehta N, Reilly MP (2008) Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr 32:638-644
28. Sitnick M, Bodine SC, Rutledge JC (2009) Chronic high fat feeding attenuates load-induced hypertrophy in mice. J Physiol 587:5753-5765
29. Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, McFarlin BK, Timmerman KL, Coen PM, Felker J, Talbert E (2005) Influence of exercise training and age on CD14+ cell-sur-face expression of toll-like receptor 2 and 4. Brain Behav Immun 19:389-397 (Pubitemid 41074777)
30. Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, Timmerman KL, McFarlin BK, Coen PM, Talbert E (2007) The influence of exercise training on inflammatory cytokines and C-reactive protein. Med Sci Sports Exerc 39:1714-1719 (Pubitemid 47511477)
31. Timmerman KL, Flynn MG, Coen PM, Markofski MM, Pence BD (2008) Exercise training-induced lowering of inXammatory (CD14+CD16+) monocytes: A role in the anti-inflammatory influence of exercise? J Leukoc Biol 84:1271-1278
32. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Synder-combe-Court D, Aganna E, Price CP, Boucher BJ (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? QJM 95:787-796 (Pubitemid 36032948)
33. Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB (2006) The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis 3:A118
34. Von Hurst PR, Stonehouse W, Coad J (2010) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient- a randomised, placebo-controlled trial. Br J Nutr 103:549-555
35. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690-693 (Pubitemid 30667088)
36. Zheng SX, Vrindts Y, Lopez M, De Groote D, Zangerle PF, Collette J, Franchimont N, Geenen V, Albert A, Reginster JY (1997) Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 26:63-71 (Pubitemid 27063783)
37. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89:1321-1327